Sphera Funds Management Ltd. Dyne Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
A detailed history of Sphera Funds Management Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 236,262 shares of DYN stock, worth $2.81 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
236,262
Previous 56,504
318.13%
Holding current value
$2.81 Million
Previous $2.03 Million
174.32%
% of portfolio
1.15%
Previous 0.37%
Shares
12 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$95.4 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$87.8 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$87.7 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$79.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$75.9 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $615M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...